<DOC>
	<DOCNO>NCT02467218</DOCNO>
	<brief_summary>Fibromyalgia ( FM ) chronic pain condition affect several million Canadians . Although etiology pathophysiology poorly understood , well-recognized association muscular pain fibromyalgia muscular hypoperfusion , hypoxia , abnormal muscle metabolism oxidative stress . Currently cure FM . Pharmacological non-pharmacological strategy direct control symptom pain , fatigue , non-restorative sleep depression . Hyperbaric oxygen therapy ( HBOT ) intermittent inhalation 100 % oxygen hyperbaric chamber pressure high 1 absolute atmosphere . Physiological effect HBOT base dramatic increase amount dissolve oxygen carry blood enables oxygenation ischemic area compromise circulation . It also activate oxidant-antioxidant system , stimulate angio- neurogenesis , modulate inflammatory response , induces brain neuroplasticity possess analgesic effect . While intervention offer benefit patient , additional treatment alternative need patient FM currently available option either ineffective poorly tolerate . Given physiological effect , HBOT could consider potential therapy treatment underlie muscular hypoxia , optimize oxidant- antioxidant system control FM symptom . The result study could therefore provide new information support basic science underling pathophysiology disease stimulate novel therapy patient suffer FM .</brief_summary>
	<brief_title>HBOT Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Function Improvement Questionnaire ( Revised ) score â‰¥ 60 baseline assessment . Women positive pregnancy test plan become pregnant study period Claustrophobia Seizure disorder Active asthma Severe chronic obstructive pulmonary disease Previous thoracic surgery History pneumothorax History severe congestive heart failure leave ventricular ejection fraction &lt; 30 % Unstable angina Chronic sinusitis Chronic acute otitis medium major ear drum trauma Current treatment bleomycin , cisplatin , doxorubicin disulfiram Participation another investigative drug device trial currently within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Hyperbaric Oxygen Treatment</keyword>
	<keyword>Fibromyalgia</keyword>
	<keyword>Global Function</keyword>
	<keyword>Sleep</keyword>
	<keyword>Chronic Pain</keyword>
	<keyword>Depression</keyword>
	<keyword>Anxiety</keyword>
</DOC>